PT  - JOURNAL ARTICLE
AU  - NITHIN B. BOPPANA
AU  - JACQUELINE M. KRAVEKA
AU  - MEHRDAD RAHMANIYAN
AU  - LI LI
AU  - ALICJA BIELAWSKA
AU  - JACEK BIELAWSKI
AU  - JASON S. PIERCE
AU  - JEREMY S. DELOR
AU  - KEZHONG ZHANG
AU  - MLADEN KORBELIK
AU  - DUSKA SEPAROVIC
TI  - Fumonisin B1 Inhibits Endoplasmic Reticulum Stress Associated-apoptosis After FoscanPDT Combined with C6-Pyridinium Ceramide or Fenretinide
DP  - 2017 Feb 01
TA  - Anticancer Research
PG  - 455--463
VI  - 37
IP  - 2
4099  - http://ar.iiarjournals.org/content/37/2/455.short
4100  - http://ar.iiarjournals.org/content/37/2/455.full
SO  - Anticancer Res2017 Feb 01; 37
AB  - Background/Aim: Combining an anticancer agent fenretinide (HPR) or C6-pyridinium ceramide (LCL29) with Foscan-mediated photodynamic therapy (FoscanPDT) is expected to augment anticancer benefits of each substance. We showed that treatment with FoscanPDT+HPR enhanced accumulation of C16-dihydroceramide, and that fumonisin B1 (FB), an inhibitor of ceramide synthase, counteracted caspase-3 activation and colony-forming ability of head and neck squamous cell carcinoma (HNSCC) cells. Because cancer cells appear to be more susceptible to increased levels of the endoplasmic reticulum (ER) stress than normal cells, herein we tested the hypothesis that FoscanPDT combined with HPR or LCL29 induces FB-sensitive ER stress-associated apoptosis that affects cell survival. Materials and Methods: Using an HNSCC cell line, we determined: cell survival by clonogenic assay, caspase-3 activity by spectrofluorometry, the expression of the ER markers BiP and CHOP by quantitative real-time polymerase chain reaction and western immunoblotting, and sphingolipid levels by mass spectrometry. Results: Similar to HPR+FoscanPDT, LCL29+FoscanPDT induced enhanced loss of clonogenicity and caspase-3 activation, that were both inhibited by FB. Our additional pharmacological evidence showed that the enhanced loss of clonogenicity after the combined treatments was singlet oxygen-, ER stress- and apoptosis-dependent. The combined treatments induced enhanced, FB-sensitive, up-regulation of BiP and CHOP, as well as enhanced accumulation of sphingolipids. Conclusion: Our data suggest that enhanced clonogenic cell killing after the combined treatments is dependent on oxidative- and ER-stress, apoptosis, and FB-sensitive sphingolipid production, and should help develop more effective mechanism-based therapeutic strategies.